@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix sdis: . @prefix do: . @prefix occursIn: . @prefix obo: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:5973; a Protein: . sub:_2 occursIn: do:162, obo:CL_0000451, obo:UBERON_0000310, species:9606; rdf:object sdis:tumor%20growth; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(HGNC:IL13) -> path(SDIS:\"tumor growth\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "20131211" . sub:_3 prov:value "In tumor beds, mDCs skew CD4þ T-cell differentiation toward a Th2 pattern (IL-13-secreting CD4þ T cells), promoting early breast cancer progression. Blockade of IL-13 partially interfered with tumor growth in a humanized breast cancer model (Aspord et al., 2007)."; prov:wasQuotedFrom pubmed:18836473 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:18836473; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:26.451+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }